Insights On Liquid Dose Manufacturing

  1. USP <788> Revisions And Why Packaging Matters More Than Ever 5/12/2026

    Prepare for the upcoming USP <788> revisions by strengthening your particulate control strategy to support regulatory compliance, product quality, and patient safety across injectable drug products.

  2. ADC Drug Products: Solutions To Manage Risks And Enhance Stability 7/2/2026

    Discover how an integrated ADC strategy addresses containment, analytics, fill-finish, and inspection challenges to improve product protection, process reliability, and delivery performance.

  3. What Biotech Startups Need To Know About Sterile Fill Finish Services 2/24/2026

    Sterile fill–finish is a critical, tightly regulated stage for biotechs, demanding strong contamination control, smart CDMO selection, and awareness of capacity, scalability, and regulatory hurdles.

  4. Streamline Your Path To Clinical Fill 5/21/2026

    Drug-independent PFS testing is a required early step — but it can be time-consuming and resource-intensive. What if you could eliminate the effort without losing the data you need?

  5. Ensuring Consistent Quality In Pharmaceutical Water For Injection (WFI) Systems Presentation 3/5/2026

    Maintaining high-purity water is vital for pharmaceutical production. Explore key strategies for system design, risk mitigation, and rigorous process control to ensure consistent regulatory compliance.

  6. Economic Advantage Of Robotic Gloveless Pharmaceutical Isolators 4/28/2025

    Are robotic gloveless isolators the key to smarter, safer, scalable solutions? Discover how they can revolutionize aseptic filling by reducing contamination, minimizing waste, and enhancing manufacturing flexibility.

  7. Planning For Scale Up: Building For Long Term Flexibility 8/31/2026

    Decisions made during clinical manufacturing have lasting consequences at commercial scale. This article examines how fill/finish equipment choices shape long-term flexibility, throughput, and operational continuity.

  8. De-Risking A Novel Valve Component For Use With Standard Syringe Systems 3/16/2026

    A novel valve provides dual‑chamber functionality within standard syringes, keeping two liquid drugs separated until injection while reducing development risk through advanced modeling.

  9. Protecting Your Drug Product: Integrating Engineering And Quality 8/31/2026

    Engineering decisions in fill/finish directly shape product quality and sterility assurance. This article examines how inert gas purging, plunger placement, dosing verification, and barrier systems interact across line design.

  10. A Risk-Based Decision Framework For Selecting Aseptic Barrier Technologies 3/20/2026

    EU GMP Annex 1 requires a risk-based approach to selecting Isolators or RABS. This framework evaluates human intervention and decontamination to ensure robust sterility assurance.